The Latest Breaking News from Amgen

The Dow Jones dropped 195 points Tuesday as Apple stock sold off on a downgrade. Tesla stock dropped despite strong fourth-quarter deliveries.

The Dow Jones Industrial Average rose Friday in the final trading session of 2023. Nvidia stock rallied on a new gaming chip for China.

The legal precedent would strongly discourage companies from trying to solve perceived problems with proposed transactions.

Antitrust overreach is hurting America's global competitiveness, with the FTC calculating industry concentration on a purely domestic basis.

Biogen and Eisai scored key victories in the quest for an Alzheimer's cure. But the race is just getting started.

Given the breakthrough developments and the rising need to treat chronic diseases, the biotech industry is well-positioned to generate returns. This might make buying biotech stocks like Organogenesis Holdings (ORGO), Innoviva (INVA), and Amgen (AMGN) a wise decision this November. Read on….

Amgen handily beat earnings forecasts Tuesday, but Amgen stock tumbled after the company scrapped an experimental prostate cancer treatment.

The Dow Jones Industrial Average dropped 125 points Tuesday after key housing data. Tesla stock continued to slide after Monday's dive.

Amgen (AMGN) is scheduled to report its third-quarter earnings soon, with Wall Street analysts expecting year-over-year improvements in revenue. However, its earnings are expected to miss the consensus estimate. Moreover, the company completed the acquisition of Horizon Therapeutics earlier this month. Considering these factors, is the stock a buy or…